Patient-Centered Outcome Measures in Lung Cancer Trials.

about

Lung Cancer in the Oldest Old: A Nation-Wide Study in The Netherlands.Chemotherapy and healthcare utilisation near the end of life in patients with cancer.Multidisciplinary decision-making regarding chemotherapy for lung cancer patients-An age-based comparison.

P2860

Q38718055-2B5FCCCC-E242-4F49-8D7D-251A0BF642B1 Q47588388-F1E278FA-7239-4283-8D55-A81F8D80ACB0 Q48303100-A9326B1C-7838-4B7B-817A-B05C0F842585

P2860

Patient-Centered Outcome Measures in Lung Cancer Trials.

Item

http://www.wikidata.org/entity/Q38861635

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Patient-Centered Outcome Measures in Lung Cancer Trials.

@en

type

Item

label

Patient-Centered Outcome Measures in Lung Cancer Trials.

@en

prefLabel

Patient-Centered Outcome Measures in Lung Cancer Trials.

@en

P1476

Patient-Centered Outcome Measures in Lung Cancer Trials.

@en

P2093

Cindy Nguyen

http://www.w3.org/2001/XMLSchema#string

Karlijn J G Schulkes

http://www.w3.org/2001/XMLSchema#string

Marije E Hamaker

http://www.w3.org/2001/XMLSchema#string

P2860

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

Early palliative care for patients with metastatic non-small-cell lung cancer

Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures.

Patient reported outcome measures (PROMs) in primary care: an observational pilot study of seven generic instruments

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.

Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting.

A novel method for expediting the development of patient-reported outcome measures and an evaluation of its performance via simulation.

Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.

Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.

The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study.

P2888

s00408-016-9903-2

P304

647-652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00408-016-9903-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P50

Leontine van Elden

F van den Bos

P577

2016-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012732493

http://www.w3.org/2001/XMLSchema#string

P698

27287676

http://www.w3.org/2001/XMLSchema#string

Patient-Centered Outcome Measures in Lung Cancer Trials.

about

P2860

P2860

Patient-Centered Outcome Measures in Lung Cancer Trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698